P. Eftychidou

Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes

A. Lallas, K. Liopyris, Z. Apalla, 2023, Medicina.

A head‐to‐head comparison of risankizumab and ixekizumab for genital psoriasis: a real‐life, 24‐week, prospective study

D. Ioannides, E. Vakirlis, A. Tsentemeidou, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Long‐term drug survival of secukinumab in real life in the era of novel biologics: a 5‐year, retrospective study, including difficult‐to‐treat areas

D. Ioannides, E. Vakirlis, E. Sotiriou, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.